CVS, Humana gain Medicare rate relief
- CVS and Humana got a real Medicare Advantage pricing break, after CMS locked in a 5.06% average 2026 payment increase for private Medicare plans. (cms.gov) - Humana’s first quarter still showed the strain — adjusted EPS fell to $10.31 from $11.58 even as revenue rose to $39.65 billion. (marketbeat.com) - The relief helps insurers stabilize bids and benefits, but it does not erase utilization pressure or the fight over prior authorization. (cms.gov)
Medicare Advantage is the business line underneath this story. It is the private-plan version of Medicare, and for big insurers like CVS’s Aetna and Humana, (cms.gov) The government already locked in a better-than-feared 2026 payment update, and now insurers are starting to say out loud that the damage from the last two years may be easing — at least a little. (cms.gov) ### What actually got better? CMS finalized a 5.06% average in(cms.gov)hat was a lot friendlier than insurers feared when the sector was still dealing with higher medical costs, lower star ratings, and tighter policy changes. Basically, the government gave plans more revenue room just as they were trying to rebuild pricing. (cms.gov) ### Why does that matter so much to CVS and Humana? Because Medicare Advantage has been the pressure point. (cms.gov)tal-benefit costs, and weaker economics on some senior plans. More revenue from CMS does not solve everything, but it gives plans more room to write 2026 bids, protect margins, and avoid another round of blunt cuts. (cms.gov) ### What did Humana say this week? Humana’s numbers showed both sides of the story. First-quarter adj(cms.gov)m $32.11 billion. So the company beat expectations on the quarter, but profits were still lower year over year — a sign that cost pressure has not disappeared just because rates improved. (marketbeat.com) ### And what about CVS? CVS has not reported first-quarter 2026 results yet — that call is scheduled for May 6, 2026 — but investors have already b(cms.gov)s Aetna. CVS previously confirmed 2026 adjusted EPS guidance of $7.00 to $7.20, and the market has been treating the CMS update as one more reason that target looks more reachable. (investors.cvshealth.com) ### Does rate relief mean the member experie(marketbeat.com) utilization management, networks, and service operations. That is the catch here. Financial relief helps the insurer first. Whether seniors feel any improvement depends on what plans do next with benefits, appeals, call-center performance, and prior-authorization rules. (cms.gov) ### Why is prior authorization still in the story? Becau(investors.cvshealth.com)educing most prior authorization requirements for about 1,500 rural hospitals and all critical access hospitals. That move does not directly change CVS or Humana’s earnings, but it shows where the pressure is going — simplify the system, especially where providers are fragile. (uhc.com) ### So is the crisis over? Probably not. The friend(cms.gov)arter made that plain. Costs are still elevated, and plans still have to prove they can price accurately, manage care without alienating members, and hold onto quality bonuses. (marketbeat.com) ### Bottom line The big change is simple — Washington gave Medicare Advantage insurers more money for 2026, and CVS and Humana look like immediate beneficiaries. But the real test comes next. If that relief only repairs margins, thi(uhc.com)viders, then it becomes a healthcare story. (cms.gov)
